RGT ASX Chart
Snapshot
Argent Biopharma Limited (RGT, formerly MGC Pharmaceuticals Ltd), is a drug development Company within the biopharmaceutical sector. The Company focuses on multidisciplinary methods with Nanotechnology, developing multi-target therapies for disease management, especially concerning the Central nervous system and Immunology treatments.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2025 YTD | |
1 Year | |
vs Sector (1yr) | - |
vs ASX 200 (1yr) | -63.59% |
Announcements
Corporate Overview
Corporate Details
Head Office | Subiaco WA 6008 |
Website | www.argentbiopharma.com |
Registry | Computershare |
Auditor | Hall Chadwick (NSW) |
Date Listed | 21 Dec 2006 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
27/02/2025 | Report (Interim) |
29/08/2025 | Report (Prelim) |
29/09/2025 | Report (Annual) |
Former Company Names
- MGC Pharmaceuticals Ltd (MXC), 02/04/2024
- Erin Resources Limited (ERI), 15/12/2015
- Health Corporation Limited (HEA), 05/09/2012
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
RGT directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of RGT directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Group Capital LLC | 06/09/2024 | 3,913,812 | 8.09 |
David Safren | 06/09/2024 | 3,405,016 | 7.03 |
Oak Capital Partners LLC | 06/09/2024 | 8,370,718 | 17.29 |
Roby Zomer | 15/10/2024 | 5,292,321 | 9.87 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
15-10-24 | Roby Zomer | 5,292,321 | -- | 9.87 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.30 | 28 June |
2023 | $0.005 | 30 June |
2022 | $0.016 | 30 June |
2021 | $0.037 | 30 June |
2020 | $0.02 | 30 June |
2019 | $0.052 | 28 June |
2018 | $0.066 | 29 June |
2017 | $0.046 | 30 June |
2016 | $0.044 | 30 June |
2015 | $0.019 | 30 June |
2014 | $0.014 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.